SSGCID

SSGCID is one of two Centers recently funded by NIAID in response to RFP-NIH-NIAID-DMID-07-19 and RFP-NIAID-DMID-NIHAI2011124 and is a consortium of four Pacific Northwest institutions ( SeattleBiomed, Beryllium, UW, and Pacific Northwest National Laboratory). The other funded center (CSGID) is based out of Chicago, IL. SSGCID’s primary mission is to determine the structure of ca. 70 protein targets from NIAID Category A-C agents, as well as emerging and re-emerging infectious disease organisms, each year for a period of five years.

SUBMIT TARGETS FOR STRUCTURE DETERMINATION

AVAILABLE MATERIAL

SSGCID clones and proteins are available to order free of charge

PUBLISH OUR STRUCTURES

We are looking for authors to drive publication of any of our structures.  Want to be first/last author? You can! Contact SSGCID Outreach.

Workshop on Structure Guided Antibiotic Development organized by CSGID and SSGCID at:

Keystone conference on Gram-Negative resistance

Organisms Studied

Overview of results

CategoryStructures
Total 757
Unique targets 597
Protein-ligand complexes 295
Selection by the scientific communityTargetsStructures
Direct request 4704 199
Nominated from SSGCID selection 1804 167
 

SSGCID is funded by Federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services, under Contract No.: HHSN272201200025C from September 1, 2012. SSGCID was funded under NIAID Contract No.: HHSN272200700057C from September 28, 2007 through September 27, 2012.

Featured Structures

Ebolavirus VP30

Recent Tweets